Early efficacy analysis of peg-interferon plus ribavirin treatment for hepatitis C recurrence after liver transplantation
10.3760/cma.j.issn.0254-1785.2013.12.005
- VernacularTitle:长效干扰素联合利巴韦林对肝移植受者丙型肝炎复发的早期疗效分析
- Author:
Tieyan FAN
;
Hong CHEN
;
Zhongyang SHEN
;
Yan TIAN
;
Xu WANG
;
Jun LI
- Publication Type:Journal Article
- Keywords:
Liver transplantation;
Hepatitis C;
Recurrence;
Interferon Alfa-2a;
Ribavirin
- From:
Chinese Journal of Organ Transplantation
2013;34(12):720-722
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy of peg-interferon plus ribavirin treatment for hepatitis C recurrence after liver transplantation.Methods The clinical data of 16 patients with hepatitis C recurrence after liver transplantation were collected from June 2002 to March 2012 in our hospital.Results There were 1620 patients receiving liver transplantation.66 of these patients received the treatment because of hepatitis C related diseases.16 of the 66 patients received peg-interferon plus ribavirin treatment after liver transplantation.The hepatitis C virus (HCV) RNA concentrations of all the 16 patients were detected.Twelve of the 16 patients were negative for HCV RNA,and the HCV RNA concentration was reduced by more than 2 log after treatment for 12 weeks in 2 cases.The early viral response (EVR) was 87.5％.The HCV RNA of all the 16 patients became negative after treatment for 24 weeks.Conclusion The EVR was high (87.5％) among patients who received peg-interferon plus ribavirin treatment after liver transplantation,and the combination therapy with interferon plus ribavirin was safe and effective for hepatitis C recurrence after liver transplantation.
